A 62‑year‑old with T2DM and CKD (eGFR 42; uACR 380 mg/g) is on ACE inhibitor and metformin. Which glucose‑lowering therapy is recommended for kidney a...

Question

A 62‑year‑old with T2DM and CKD (eGFR 42; uACR 380 mg/g) is on ACE inhibitor and metformin. Which glucose‑lowering therapy is recommended for kidney and CV protection?

Accepted Answer

SGLT2 inhibitor (e.g., empagliflozin) if eGFR ≥20 mL/min/1.73 m²

Answer

DPP‑4 inhibitor

Answer

Sulfonylurea

Answer

Thiazolidinedione

Answer

Basal insulin first

us-abfm MCQ (SBA): T2DM with CKD-SGLT2 Benefit

A 62‑year‑old with T2DM and CKD (eGFR 42; uACR 380 mg/g) is on ACE inhibitor and metformin. Which glucose‑lowering therapy is recommended for kidney and CV protection?